PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
13-Aug-2020 SMi’s Pharmaceutical Microbiology East Coast Conference - A Virtual Conference with Remote Access Only SMi Group
13-Aug-2020 HOLOGRAPHIC LABELS SUCCESSFULLY PRESCRIBED IN BATTLE TO FOIL COUNTERFEITERS Eltronis
12-Aug-2020 Ligandal develops effective antidote to SARS-CoV-2 Liganda
12-Aug-2020 Cough and cold-killing extract to be grown hydroponically creating reliable, year-round source for first time Vertical Future
12-Aug-2020 PTC Therapeutics Announces FDA Approval of Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older PTC Therapeutics, Inc
12-Aug-2020 FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting FibroGenesis
12-Aug-2020 Advent Life Sciences announces sale of its portfolio Company KaNDy Therapeutics to Bayer AG for USD 425M upfront plus USD 450M in potential development milestones followed by further potential commercial milestones Advent Life Sciences
12-Aug-2020 Newron Pharmaceuticals provides clinical and business update Newron Pharmaceuticals
12-Aug-2020 Pre-Close Trading Statement Sareum Holdings PLC
12-Aug-2020 Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication Saillant Therapeutics
12-Aug-2020 Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates Abeona Therapeutics
12-Aug-2020 CPhI South East Asia rescheduled for 2021 CPhI SEA
11-Aug-2020 Genomenon’s Klein Named in “Top 25 Biotechnology CEOs of 2020” by TechCEOs Genomeon
10-Aug-2020 How COVID-19 changed the way patients responded to a heart attack University of Leeds
10-Aug-2020 Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID) Eli Lilly and Company
10-Aug-2020 BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China BioNTech SE
10-Aug-2020 CIMZIA® is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum UCB
10-Aug-2020 Lundbeck discontinues phase II proof of concept study of Lu AF11167 in patients with negative symptoms of schizophrenia H. Lundbeck A/S
10-Aug-2020 Fujifilm Selects Kinaxis RapidResponse for Agility in its Medical System Supply Chain Kinaxis Inc
10-Aug-2020 Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers Clovis Oncology, Inc